Tirzepatide Significantly Reduces HbA1c, Body Weight in Type 1 Diabetes
A new proof-of-concept observation study reports the dual GLP-1/GIP agonist's positive efficacy and safety for adults with T1D.
Stay updated with breaking news from Jacobs School. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new proof-of-concept observation study reports the dual GLP-1/GIP agonist's positive efficacy and safety for adults with T1D.
A highly sensitive graphene sensor that can detect incredibly low quantities of lead ions in water has been created by engineers at the University of California, San Diego.
Jan. 12, 1953 – Jan. 22, 2024
Targeted News Service provides Washington Bureau coverage, federal contract and contracting information for awards and for subcontracting opportunities, a congressional vote chart, federal and congressional press releases.
UCSD also announces that it spent $1.53 billion on research in fiscal 2022, ranking seventh among American universities.